spacer
home > pmps > spring 2007 > changing clinical trials landscape
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Changing Clinical Trials Landscape

As trials become increasingly globalised, Chris Wilson of Keats Healthcare tells PMPS how bespoke supply solutions can bring down costs

Where do you see Keats Healthcare in five years’ time?

Although the clinical trials landscape is constantly evolving to meet the challenges of both pharma and regulatory authorities, I’m confident that Keats will be at the forefront of clinical trials comparator supply. As supply chains become ever more complex and critical, Keats will continue to service the needs of the global industry by adding value to clinical trial operations. There has been a lot of talk about escalating clinical trial costs, with the cost of bringing a product to market regularly put at over $US 1 billion. Most people know that this figure is manipulated, but it should be remembered that the adjustments are made to include not only the cost of molecules that fail in the early stages of testing, but also the huge cost to the industry of trials that collapse because of poor supplies – comparator availability is a huge part of that. What is certain is that with the increased prevalence of biologics and cold chain products in trials, companies need to have confidence in their comparator supply. The industry wants full pipelines, and is rightly looking to cut trial costs and durations, but we must be careful not to cut costs in the wrong places.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
After receiving an MA in Retail and Marketing from Manchester University, Chris Wilson began his career in the brewing and licensed retail industry with Carlsberg in Denmark, with roles including sales, procurement and marketing directorships. From there he was responsible for launching a leading branded wine with Pernod Ricard and spent a period as Head of Sales and Marketing at Sky TV. Chris joined Keats Healthcare Ltd as Managing Director, with a focus on providing clients with flexible and efficient clinical trial comparator supply solutions.
spacer
Chris Wilson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round

Cambridge, UK, 10 June 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment. The funding will be used as working capital for the Company’s Cyto-Mine® Single Cell Analysis System, expansion of the UK facility and enable the doubling of personnel through the opening of a new US Sales Office and Demo Lab in California.
More info >>

White Papers

Key to Outsourcing Method Development and Validation A Pragmatic Approach

RSSL

In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developer’s mind set and a regulatory background in validation.
More info >>

 
Industry Events

FlyPharma Europe

22-23 October 2019, Copenhagen, Denmark

The FlyPharma Conference Europe 2019 is aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chain. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. There will be plenty of networking opportunities, including a complimentary evening networking event, where delegates can meet and catch up with senior and executive pharma and cargo professionals – gaining strong, new industry contacts and building on existing ones.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement